BIOMAT Database Logo BIOMAT Database Logo

Differential efficacy of L-deprenyl, a selective MAO type-B inhibitor, in endogenous and nonendogenous depression. 1982

J J Mann, and A Frances, and E D Peselow, and S Gershon

UI MeSH Term Description Entries
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012642 Selegiline A selective, irreversible inhibitor of Type B monoamine oxidase that is used for the treatment of newly diagnosed patients with PARKINSON DISEASE, and for the treatment of depressive disorders. The compound without isomeric designation is Deprenyl. Deprenalin,Deprenil,Deprenyl,E-250,Eldepryl,Emsam,Humex,Jumex,L-Deprenyl,Selegiline Hydrochloride,Selegiline Hydrochloride, (R)-Isomer,Selegiline Hydrochloride, (R,S)-Isomer,Selegiline Hydrochloride, (S)-Isomer,Selegiline, (R)-Isomer,Selegiline, (R,S)-Isomer,Selegiline, (S)-Isomer,Selegyline,Yumex,Zelapar,E 250,E250

Related Publications

J J Mann, and A Frances, and E D Peselow, and S Gershon
L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.
March 1980, Life sciences,
J J Mann, and A Frances, and E D Peselow, and S Gershon
(-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
January 2004, Neurotoxicology,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO "type B" inhibitor.
January 1978, Journal of neural transmission,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
February 1986, Xenobiotica; the fate of foreign compounds in biological systems,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats.
June 1991, Pharmacology, biochemistry, and behavior,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Selegiline HC1: Selective MAO-type B inhibitor.
October 1990, Neurology,
J J Mann, and A Frances, and E D Peselow, and S Gershon
(-)-Deprenyl a selective MAO "B' inhibitor, increases [3H]imipramine binding and decreases beta-adrenergic receptor function.
April 1983, European journal of pharmacology,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease.
January 1980, British journal of clinical pharmacology,
J J Mann, and A Frances, and E D Peselow, and S Gershon
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.
January 2005, Clinical neuropharmacology,
J J Mann, and A Frances, and E D Peselow, and S Gershon
The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
July 1994, Brain research,
Copied contents to your clipboard!